OpenAlex
PricingAboutJobs
Log inGet started
Work

Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return?

HTML

Year: 2014
Type: review
Source: Expert Opinion on Biological Therapy
DOI: 10.1517/14712598.2014.935332
Authors: Francesco Panza, Vincenzo Solfrizzi, Bruno P Imbimbo, Giancarlo Logroscino
Institutions: University of Bari Aldo Moro, Chiesi (Italy)
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, amyloid-beta, monoclonal antibodies, bapineuzumab, solanezumab, gantenerumab, crenezumab, secondary prevention, cognitive effects, fibrillar amyloid-beta, amyloid-beta oligomers
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2149227806
FWCI: 0.975
Cites: 77
Cited by: 88
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security